These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32249620)

  • 1. Risk assessment of venous thromboembolism in hematological cancer patients: a review.
    Chan TS; Hwang YY; Tse E
    Expert Rev Hematol; 2020 May; 13(5):471-480. PubMed ID: 32249620
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thromboembolism incidence in hematologic malignancies.
    Kekre N; Connors JM
    Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic risk in hematological malignancies.
    Franchini M
    Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.
    Gade IL; Brækkan S; Næss IA; Hansen JB; Rosendaal F; Cannegieter S; Overvad K; Jensvoll H; Hammerstrøm J; Gran OV; Tjønneland A; Kristensen SR; Severinsen MT
    Thromb Res; 2017 Oct; 158():157-160. PubMed ID: 28926801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study.
    Adelborg K; Corraini P; Darvalics B; Frederiksen H; Ording A; Horváth-Puhó E; Rørth M; Sørensen HT
    J Thromb Haemost; 2019 Aug; 17(8):1305-1318. PubMed ID: 31054195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies.
    Sorigue M; Cañamero E; Siguenza P; Nomdedeu M; López-Núñez JJ
    Leuk Lymphoma; 2020 Jun; 61(6):1277-1291. PubMed ID: 31960713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M
    J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M; Russo L
    Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.
    Annibali O; Napolitano M; Avvisati G; Siragusa S
    Crit Rev Oncol Hematol; 2018 Apr; 124():41-50. PubMed ID: 29548485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and risk stratification in hematological malignancies.
    Sanfilippo KM
    Thromb Res; 2022 May; 213 Suppl 1():S16-S21. PubMed ID: 36210555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011-2015.
    Bakalov V; Tang A; Yellala A; Kaplan R; Lister J; Sadashiv S
    Leuk Lymphoma; 2020 Feb; 61(2):370-376. PubMed ID: 31545108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.
    Wun T; White RH
    Thromb Res; 2010 Apr; 125 Suppl 2():S96-102. PubMed ID: 20434017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in patients with myeloma: incidence and risk factors in a "real-world" population.
    Crowley MP; Eustace JA; O'Shea SI; Gilligan OM
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):600-6. PubMed ID: 24486624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
    Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
    Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis and bleeding in hematological malignancy.
    Wang TF; Leader A; Sanfilippo KM
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101353. PubMed ID: 36030068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.
    Wille K; Sadjadian P; Becker T; Kolatzki V; Horstmann A; Fuchs C; Griesshammer M
    Ann Hematol; 2019 Jan; 98(1):93-100. PubMed ID: 30155552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
    Goyal G; Bhatt VR
    Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.
    Streiff MB
    Clin Adv Hematol Oncol; 2013 Jun; 11(6):349-57. PubMed ID: 24472803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.